Jinlan 98+ EP/BP/USP Elbasvir
1370468-36-2
medical grade
98%
Shanghai/Ningbo/Qingdao
Jinlan
25kg/Cardboard Drum
Yes
2026-03-01
Peptides,API,Intermediate
-
Product Details
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceChEBI: A complex organic heterotetracyclic compound that is a hepatitis C virus nonstructural protein 5A inhibitor used in combination with grazoprevir (under the brand name Zepatier) for treatment of chronic HCV genotypes 1 or 4 infection in adults.Basic Info
-
Product Name:
Elbasvir
Other Name:Elbasvir;Elbasvir/MK-8742;MK-8742 Elbasvir;MK-8742; MK8742; MK 8742;Albasvir;Carbamic acid, N,N'-[[(6S)-6-phenyl-6H-indolo[1,2-c][1,3]benzoxazine-3,10-diyl]bis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester;Dimethyl ((2S,2'S)-((2S,2'S)-2,2'-(5,5'-((S)-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole-3,10-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dicarbamate;Elbasvir, 10 mM in DMSO
CAS No.:1370468-36-2
Molecular Formula:C49H55N9O7
InChIKeys:InChIKey=BVAZQCUMNICBAQ-PZHYSIFUSA-N
Molecular Weight:882.02
Exact Mass:882.02
Color/Form:White to yellow
Categories:
Characteristics-
Density:
1.40±0.1 g/cm3(Predicted)
PKA:11.22±0.46(Predicted)
Critical Temperature & Pressure:2-8°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptides,API,Intermediate
-
Location:
Room 606, Building 1, Fu Yi Commercial Center, Shangcheng District, Hangzhou City, Zhejiang Province - 1
-
Payment Terms:
100% TT in advance
-
Average lead Time:
275 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
51-100
-
Year of Establishment:
2020
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
-
Jinlan 98+ EP/BP/USP Apalutamide
medical grade / 98%
-
-
-
-
Jinlan 98+ Veterinary Use Lotilaner EP/BP/USP
medical grade / 98%
-
-
-
-
Jinlan 98+ EP/BP/USP Ipilimumab
medical grade / 98%
-
-
-
-
Jinlan 98+ EP/BP/USP Midostaurin
medical grade / 98%
-
-
-
-
Jinlan 98+ EP/BP/USP Bevacizumab
medical grade / 98%
-
-
-
-
Jinlan 98+ EP/BP/USP Nilotinib HCL
medical grade / 98%
-